The alteration of gut microbiota in newly-diagnosed type 2 diabetic patients

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

Aims Gut microbiota dysbiosis is known to be associated with diabetes, however the findings of previous studies are conflicting. To clarify the association between type 2 diabetes and the gut microbiota, the present study analyzed the composition of fecal gut microbiota and its correlation with specific clinical parameters in newly-diagnosed, treatment-naive diabetic patients and healthy controls. Methods A total of 50 patients with newly diagnosed type 2 diabetes and 50 healthy control subjects were enrolled in the study. Fecal samples, blood samples and food diaries were collected from the diabetic patients prior to, and 3-months after the start of their anti-diabetic treatment. These samples were also collected from the healthy controls. The gut microbiota was characterized by 16S rRNA analysis using quantitative polymerase chain reaction. Results The fecal count of Lactobacillus was significantly higher, while Clostridium coccoides and Clostridium leptum were significantly lower in the diabetic patients compared with the healthy controls. Lactobacillus was significantly positively correlated with glucose, glycated hemoglobin, and the homeostatic model assessment, whereas C. coccoides and C. leptum were significantly negatively correlated with the diabetic parameters. In addition, the newly-diagnosed diabetic patients had a significant decrease in the presence of C. coccoides and C. leptum after 3 months of treatment compared with before treatment. Conclusions The amount of fecal Lactobacillus, C. coccoides and C. leptum was significantly different between the patients with type 2 diabetes and the healthy controls. The levels of Clostridium were also significantly changed after 3-months of treatment in the diabetic patients. Further research is needed to clarify the correlation or causal relationship between the gut microbiota dysbiosis and type 2 diabetes.
原文英語
頁(從 - 到)51-56
期刊Nutrition
63
DOIs
出版狀態已發佈 - 七月 2019

指紋

Type 2 Diabetes Mellitus
Clostridium
Lactobacillus
Dysbiosis
Therapeutics
Diet Records
Glycosylated Hemoglobin A
Gastrointestinal Microbiome
Healthy Volunteers
Glucose
Polymerase Chain Reaction
Research

Keywords

  • Human gut microbiota
  • Type 2 diabetes
  • Dysbiosis
  • LPS, lipopolysaccharide
  • qPCR, polymerase chain reaction
  • LDL, Low density lipoprotein
  • HDL, high density lipoprotein
  • IL-1β, interleukin-1β
  • TNF-α, tumor necrosis factor-α
  • GLP-1, glucagon-like peptide-1
  • HOMA-IR, homeostatic model assessment-insulin resistance

引用此文

The alteration of gut microbiota in newly-diagnosed type 2 diabetic patients. / Chen, Pei-Chi; Chien, Yi-Wen; Yang, Suh-Ching.

於: Nutrition, 卷 63, 07.2019, p. 51-56.

研究成果: 雜誌貢獻文章

@article{917867040baf4953b77a45f81faaa228,
title = "The alteration of gut microbiota in newly-diagnosed type 2 diabetic patients",
abstract = "Aims Gut microbiota dysbiosis is known to be associated with diabetes, however the findings of previous studies are conflicting. To clarify the association between type 2 diabetes and the gut microbiota, the present study analyzed the composition of fecal gut microbiota and its correlation with specific clinical parameters in newly-diagnosed, treatment-naive diabetic patients and healthy controls. Methods A total of 50 patients with newly diagnosed type 2 diabetes and 50 healthy control subjects were enrolled in the study. Fecal samples, blood samples and food diaries were collected from the diabetic patients prior to, and 3-months after the start of their anti-diabetic treatment. These samples were also collected from the healthy controls. The gut microbiota was characterized by 16S rRNA analysis using quantitative polymerase chain reaction. Results The fecal count of Lactobacillus was significantly higher, while Clostridium coccoides and Clostridium leptum were significantly lower in the diabetic patients compared with the healthy controls. Lactobacillus was significantly positively correlated with glucose, glycated hemoglobin, and the homeostatic model assessment, whereas C. coccoides and C. leptum were significantly negatively correlated with the diabetic parameters. In addition, the newly-diagnosed diabetic patients had a significant decrease in the presence of C. coccoides and C. leptum after 3 months of treatment compared with before treatment. Conclusions The amount of fecal Lactobacillus, C. coccoides and C. leptum was significantly different between the patients with type 2 diabetes and the healthy controls. The levels of Clostridium were also significantly changed after 3-months of treatment in the diabetic patients. Further research is needed to clarify the correlation or causal relationship between the gut microbiota dysbiosis and type 2 diabetes.",
keywords = "Human gut microbiota, Type 2 diabetes, Dysbiosis, LPS, lipopolysaccharide, qPCR, polymerase chain reaction, LDL, Low density lipoprotein, HDL, high density lipoprotein, IL-1β, interleukin-1β, TNF-α, tumor necrosis factor-α, GLP-1, glucagon-like peptide-1, HOMA-IR, homeostatic model assessment-insulin resistance",
author = "Pei-Chi Chen and Yi-Wen Chien and Suh-Ching Yang",
year = "2019",
month = "7",
doi = "10.1016/j.nut.2018.11.019",
language = "English",
volume = "63",
pages = "51--56",
journal = "Nutrition",
issn = "0899-9007",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - The alteration of gut microbiota in newly-diagnosed type 2 diabetic patients

AU - Chen, Pei-Chi

AU - Chien, Yi-Wen

AU - Yang, Suh-Ching

PY - 2019/7

Y1 - 2019/7

N2 - Aims Gut microbiota dysbiosis is known to be associated with diabetes, however the findings of previous studies are conflicting. To clarify the association between type 2 diabetes and the gut microbiota, the present study analyzed the composition of fecal gut microbiota and its correlation with specific clinical parameters in newly-diagnosed, treatment-naive diabetic patients and healthy controls. Methods A total of 50 patients with newly diagnosed type 2 diabetes and 50 healthy control subjects were enrolled in the study. Fecal samples, blood samples and food diaries were collected from the diabetic patients prior to, and 3-months after the start of their anti-diabetic treatment. These samples were also collected from the healthy controls. The gut microbiota was characterized by 16S rRNA analysis using quantitative polymerase chain reaction. Results The fecal count of Lactobacillus was significantly higher, while Clostridium coccoides and Clostridium leptum were significantly lower in the diabetic patients compared with the healthy controls. Lactobacillus was significantly positively correlated with glucose, glycated hemoglobin, and the homeostatic model assessment, whereas C. coccoides and C. leptum were significantly negatively correlated with the diabetic parameters. In addition, the newly-diagnosed diabetic patients had a significant decrease in the presence of C. coccoides and C. leptum after 3 months of treatment compared with before treatment. Conclusions The amount of fecal Lactobacillus, C. coccoides and C. leptum was significantly different between the patients with type 2 diabetes and the healthy controls. The levels of Clostridium were also significantly changed after 3-months of treatment in the diabetic patients. Further research is needed to clarify the correlation or causal relationship between the gut microbiota dysbiosis and type 2 diabetes.

AB - Aims Gut microbiota dysbiosis is known to be associated with diabetes, however the findings of previous studies are conflicting. To clarify the association between type 2 diabetes and the gut microbiota, the present study analyzed the composition of fecal gut microbiota and its correlation with specific clinical parameters in newly-diagnosed, treatment-naive diabetic patients and healthy controls. Methods A total of 50 patients with newly diagnosed type 2 diabetes and 50 healthy control subjects were enrolled in the study. Fecal samples, blood samples and food diaries were collected from the diabetic patients prior to, and 3-months after the start of their anti-diabetic treatment. These samples were also collected from the healthy controls. The gut microbiota was characterized by 16S rRNA analysis using quantitative polymerase chain reaction. Results The fecal count of Lactobacillus was significantly higher, while Clostridium coccoides and Clostridium leptum were significantly lower in the diabetic patients compared with the healthy controls. Lactobacillus was significantly positively correlated with glucose, glycated hemoglobin, and the homeostatic model assessment, whereas C. coccoides and C. leptum were significantly negatively correlated with the diabetic parameters. In addition, the newly-diagnosed diabetic patients had a significant decrease in the presence of C. coccoides and C. leptum after 3 months of treatment compared with before treatment. Conclusions The amount of fecal Lactobacillus, C. coccoides and C. leptum was significantly different between the patients with type 2 diabetes and the healthy controls. The levels of Clostridium were also significantly changed after 3-months of treatment in the diabetic patients. Further research is needed to clarify the correlation or causal relationship between the gut microbiota dysbiosis and type 2 diabetes.

KW - Human gut microbiota

KW - Type 2 diabetes

KW - Dysbiosis

KW - LPS, lipopolysaccharide

KW - qPCR, polymerase chain reaction

KW - LDL, Low density lipoprotein

KW - HDL, high density lipoprotein

KW - IL-1β, interleukin-1β

KW - TNF-α, tumor necrosis factor-α

KW - GLP-1, glucagon-like peptide-1

KW - HOMA-IR, homeostatic model assessment-insulin resistance

U2 - 10.1016/j.nut.2018.11.019

DO - 10.1016/j.nut.2018.11.019

M3 - Article

VL - 63

SP - 51

EP - 56

JO - Nutrition

JF - Nutrition

SN - 0899-9007

ER -